SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jinping Shi who wrote (309)1/23/1997 7:55:00 PM
From: I. Luttichuys   of 1762
 
Hello Jinping, If you mean "controls" there weren't any which, I believe, is standard for trials involving a condition like non-hodgkin's lymphoma. It would be unethical to give placebo under such circumstances.
I believe that the FDA has given indication that IDEC's application may be handled by "fast-track" and IDEC has indicated themselves that approval may be expected in the "later half" of the year.
My experience with IDEC is such that I trust implicitly that they will have an answer when IDEC says they will or sooner (barring any unforeseeable circumstances).
Have a Good Evening,
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News